Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + amodiaquine efficacy study for uncomplicated falciparum malaria in Eritrea
ACTRN12618000353291Phase 4Completed
- Sponsor
- Ministry of Health of Eritrea
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in malaria and Malaria, sponsored by Ministry of Health of Eritrea. Primary endpoint: Percent of treatment failures. Started Sep 2016; status: completed.
02
Drugs
artesunateamodiaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12618000353291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000353291.